Endo International (ENDP) Tops Q1 EPS by 12c, Affirms Gudiance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- Reddit to join S&P 500 index on Aug. 18, shares leap
Endo Reports First-Quarter 2018 Financial Results
May 8, 2018 6:30 AM EDTDUBLIN, May 8, 2018 /PRNewswire/ --
First-quarter 2018 revenues of $701 million First-quarter 2018 Branded Specialty Products revenues increased 7 percent versus first-quarter 2017 to $112 million First-quarter 2018 XIAFLEX® franchise revenues increased 15 percent versus first-quarter 2017 to $57 million First-quarter 2018 Sterile Injectables revenues increased 25 percent versus first-quarter 2017 to $216 million First-quarter 2018 reported (GAAP) net loss of $505 million driven by pre-tax, non-cash asset impairment charges of $448 million First-quarter 2018 adjusted EBITDA of $334 million Company affirms 2018 full-year revenues, adjusted EBITDA and adjusted EPS guidanceEndo International plc (NASDAQ:... More
